Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions

March 4, 2024

US Army Medical Research and Development Command Vendor Day

Los Angeles, CA, March 04, 2024 (GLOBE NEWSWIRE) — SofPulse Inc. — a subsidiary of Endonovo (OTC PINK: ENDV) and a proposed spin-off company — announced today the participation of its SofPulse® Pulsed Electro-Magnetic Field (PEMF) FDA-cleared medical device in the United States Army Medical Research and Development Command (USAMRDC) May 2024 Vendor Day.

Read more at globenewswire.com

Related news for (ENDV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.